News & Events

Stay up to date on the latest news, milestones and events from Fesarius Therapeutics.

citybiz: Fesarius Therapeutics Raises $20 Million Series A to Expand Commercial Adoption of DermiSphere

BioSpace: FesariusTherapeutics Closes Oversubscribed $20M Series A

FesariusTherapeutics Closes Oversubscribed $20M Series A, Led by Jefferson Life Sciences

Fesarius Therapeutics Demonstrates the Science That Establishes DermiSphere™ hDRT in a Class of Its Own

Dermatology Times: FDA Approves Collagen-Based DermiSphere Hydrogel

January 8, 2025

Dermatology Times: DermiSphere Offers More Affordable Treatment for Full Thickness Skin Loss

No news or events match your search. Try another term or show all news & events.

Connect With Fesarius

Learn more about Fesarius Therapeutics and DermiSphere™ hDRT.

Contact Fesarius